Endocrine Abstracts

Previous issue | Volume 84 | ETA2022 | Next issue

44th Annual Meeting of the European Thyroid Association (ETA) 2022

Brussels, Belgium
10 Sept 2022 - 13 Sept 2022

Oral Presentations

Oral Session 7: Thyroid Cancer Basic

Previous section
Oral Session 6: Hypothyroidism

Table of contents

Next section
Oral Session 8: Basic 2

ea0084op-07-32 | Oral Session 7: Thyroid Cancer Basic

The micro-rna content of extracellular vesicles in papillary thyroid cancer: from identification in mouse thyroid tumour to detection in patient plasma

ea0084op-07-33 | Oral Session 7: Thyroid Cancer Basic

HüRthle cell tumors vs oncocytic variants of the follicular cell derived thyroid tumours: a comprehensive analysis based in transcriptome, proteome and cnv profiling

ea0084op-07-34 | Oral Session 7: Thyroid Cancer Basic

CDK4 phosphorylation status and rational use of CDK4/6 inhibitors in advanced thyroid cancers

ea0084op-07-35 | Oral Session 7: Thyroid Cancer Basic

RET fusion genes in a large cohort of papillary thyroid carcinomas

ea0084op-07-36 | Oral Session 7: Thyroid Cancer Basic

Loss of tumor cell MHC class ii expression as driver of relapse to dabrafenib and trametinib in mouse BRAF-mutant anaplastic thyroid cancer

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more